US 10947317
NaPi2b-targeted antibody-drug conjugates and methods of use thereof
granted A61KA61K47/6805A61K47/6811
Quick answer
US patent 10947317 (NaPi2b-targeted antibody-drug conjugates and methods of use thereof) held by Mersana Therapeutics, Inc. expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mersana Therapeutics, Inc.
- Grant date
- Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K47/6805, A61K47/6811, A61K47/6851, A61K47/6857